Therapist perspectives on telehealth-based virtual reality exposure therapy.

Clinical practice Exposure therapy Mental health Telehealth Virtual reality

Journal

Virtual reality
ISSN: 1359-4338
Titre abrégé: Virtual Real
Pays: England
ID NLM: 101518169

Informations de publication

Date de publication:
2024
Historique:
medline: 6 9 2024
pubmed: 6 9 2024
entrez: 6 9 2024
Statut: ppublish

Résumé

Virtual reality (VR) can enhance mental health care. In particular, the effectiveness of VR-based exposure therapy (VRET) has been well-demonstrated for treatment of anxiety disorders. However, most applications of VRET remain localized to clinic spaces. We aimed to explore mental health therapists' perceptions of telehealth-based VRET (tele-VRET) by conducting semi-structured, qualitative interviews with 18 telemental health therapists between October and December 2022. Interview topics included telehealth experiences, exposure therapy over telehealth, previous experiences with VR, and perspectives on tele-VRET. Therapists described how telehealth reduced barriers (88.9%, 16/18), enhanced therapy (61.1%, 11/18), and improved access to clients (38.9%, 7/18), but entailed problems with technology (61.1%, 11/18), uncontrolled settings (55.6%, 10/18), and communication difficulties (50%, 9/18). Therapists adapted exposure therapy to telehealth by using online resources (66.7%, 12/18), preparing client expectations (55.6%, 10/18), and adjusting workflows (27.8%, 5/18). Most therapists had used VR before (72.2%, 13/18) and had positive impressions of VR (55.6%, 10/18), but none had used VR clinically. In response to tele-VRET, therapists requested interactive session activities (77.8%, 14/18) and customizable interventions components (55.6%, 10/18). Concerns about tele-VRET included risks with certain clients (77.8%, 14/18), costs (50%, 9/18), side effects and privacy (22.2%, 4/18), and inappropriateness for specific forms of exposure therapy (16.7%, 3/18). These results reveal how combining telehealth and VRET may expand therapeutic options for mental healthcare providers and can help inform collaborative development of immersive health technologies.

Identifiants

pubmed: 39238767
doi: 10.1007/s10055-024-00956-7
pmc: PMC11376200
pii:
doi:

Types de publication

Journal Article

Langues

eng

Déclaration de conflit d'intérêts

Competing interests Dr. Welch is a shareholder, and all other authors are employees of Doxy.me Inc., a commercial telemedicine company. The authors declare no other conflicts of interest.

Auteurs

Triton Ong (T)

Doxy.Me Research, Doxy.Me Inc, Rochester, NY, USA.

Julia Ivanova (J)

Doxy.Me Research, Doxy.Me Inc, Rochester, NY, USA.

Hiral Soni (H)

Doxy.Me Research, Doxy.Me Inc, Rochester, NY, USA.

Hattie Wilczewski (H)

Doxy.Me Research, Doxy.Me Inc, Rochester, NY, USA.

Janelle Barrera (J)

Doxy.Me Research, Doxy.Me Inc, Rochester, NY, USA.
Department of Psychiatry and Behavioral Neurosciences, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.

Mollie Cummins (M)

Doxy.Me Research, Doxy.Me Inc, Rochester, NY, USA.
College of Nursing and Department of Biomedical Informatics, University of Utah, Salt Lake City, UT, USA.

Brandon M Welch (BM)

Doxy.Me Research, Doxy.Me Inc, Rochester, NY, USA.
Biomedical Informatics Center, Medical University of South Carolina, Public Health and Sciences, Charleston, SC, USA.

Brian E Bunnell (BE)

Doxy.Me Research, Doxy.Me Inc, Rochester, NY, USA.
Department of Psychiatry and Behavioral Neurosciences, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.

Classifications MeSH